SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.1 (50 micrograms/50 micrograms)/ml, injectable dispersion, Vaccin à ARNm contre la COVID-19 50 doses
Active ingredients: IMÉLASOMÉRAN, ÉLASOMÉRAN
Commercialized according to BDPMDispensing in France: Prescription only
Injectable dispersion50 dosesintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.1 (50 microgrammes/50 microgrammes)/ml, dispersion injectable, Vaccin à ARNm contre la COVID-19
- Pharmaceutical form
- dispersion injectable
- Route of administration
- intramusculaire
- Presentation description
- 10 flacon(s) multidose(s) en verre de 5 dose(s)
- Marketing authorisation holder
- MODERNA BIOTECH SPAIN SL (ESPAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Jan 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
62609613CIP73025952CIP133400930259528Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IMÉLASOMÉRANdispersion | 25 microgrammes · une dose de 0,5 mL ou 12,5 microgrammes pour une dose de 0,25 mL | SA |
| ÉLASOMÉRANdispersion | 25 microgrammes · une dose de 0,5 mL ou 12,5 microgrammes pour une dose de 0,25 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.